<html>
<head><title>
Prepared and filed by St Ives Financial
</title>
</head>
<body bgcolor="#FFFFFF">
<page>
<p align="center"><font size="2" face="serif"><b>UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION<br>Washington, D.C. 20549</b></font></p>
<p align="center"><b><font face="serif" size="4">FORM 8-K</font></b></p>
<p align="center"><font size="2" face="serif"><b>CURRENT REPORT<br>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></font></p>
<p align="center"><font size="2" face="serif">Date of report (Date of earliest event reported):  December 29, 2006</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">&nbsp;</font></td>
<td align="center"><font size="2" face="serif"><b><u>Impax Laboratories, Inc.<br></u></b>(Exact name of registrant as specified in its charter)</font></td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top" bgcolor="#ffffff">
  <td width="20%" align="left"><div align="center"></div></td>
  <td width="20%" align="right"><div align="center"></div></td>
  <td width="20%" align="right"><div align="center"></div></td>
  <td width="20%" align="left"><div align="center"></div></td>
  <td width="20%" align="right"><div align="center"></div></td>
  </tr>
<tr valign="top" bgcolor="#ffffff">
<td width="20%" align="left"><div align="center"><font size="2" face="serif"><b><u>Delaware</u></b></font></div></td>
<td width="20%" align="right"><div align="center"></div></td>
<td width="20%" align="right"><div align="center"><u><font size="2" face="serif"><b>0-27354</b></font></u></div></td>
<td width="20%" align="left"><div align="center"></div></td>
<td width="20%" align="right"><div align="center"><u><font size="2" face="serif"><b>65-0403311</b></font></u></div></td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td width="20%" align="left"><div align="center"><font size="2" face="serif">(State or other jurisdiction<br>
  of incorporation)</font></div></td>
<td width="20%" align="right"><div align="center"></div></td>
<td width="20%" align="center"><div align="center"><font size="2" face="serif">(Commission<br>
  File Number)</font></div></td>
<td width="20%" align="left"><div align="center"></div></td>
<td width="20%" align="center"><div align="center"><font size="2" face="serif">(I.R.S. Employer<br>
  Identification No.)</font></div></td>
</tr>
</table>
<br><br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="center"><font size="2" face="serif"><b><u>30831 Huntwood Ave., Hayward, CA 94544</u></b></font></td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif">(Address of principal executive offices) (Zip Code)</font></td>
</tr>
</table>
<br><br>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top" bgcolor="#ffffff">
<td align="center"><font size="2" face="serif"><b><u>510-476-2000</u></b></font></td>
<td align="left" width="2%">&nbsp;</td> </tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="center"><font size="2" face="serif">(Registrant&#8217;s telephone number, including area code)  </font></td>
<td align="left">&nbsp;</td>
</tr>
</table>
<br><br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="center"><font size="2" face="serif"><b><u>Not Applicable</u></b></font></td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif">(Former name or former address, if changed since last report)</font></td>
</tr>
</table>
<p align="left"><font size="2" face="serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></p>  <table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="3%"><font size="2" face="serif"><img src="emptybox.gif" width="12" height="12"></font></td>
<td align="left"><font size="2" face="serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></td>
</tr>
<tr valign="top">
<td width="3%">&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td width="3%" align="left"><font size="2" face="serif"><img src="emptybox.gif" width="12" height="12"></font></td>
<td align="left"><font size="2" face="serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></td>
</tr>
<tr valign="top">
<td width="3%">&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td width="3%" align="left"><font size="2" face="serif"><img src="emptybox.gif" width="12" height="12"></font></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></td>
</tr>
<tr valign="top">
<td width="3%">&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td width="3%" align="left"><font size="2" face="serif"><img src="emptybox.gif" width="12" height="12"></font></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></td>
</tr>
</table>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<p align="left"><font size="2" face="serif"><b>Item 8.01&nbsp;&nbsp;&nbsp;Other Events.</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On December 29, 2006, the Securities and Exchange Commission issued an order instituting an administrative proceeding to determine whether, in light of the registrant&#8217;s failure to file periodic reports since September 2004, the registration of its securities under Section 12 of the Securities Exchange Act of 1934 should be suspended or revoked.  An Administrative Law Judge will consider the evidence in this matter and is ordered to issue an initial decision within 120 days.  Also on December 29, 2006, the SEC suspended trading in Impax shares during the 10-business-day period from December 29, 2006 through January 16, 2007 because of the registrant&#8217;s failure to file periodic reports.  </font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A copy of Impax&#8217;s press release concerning the foregoing is attached as Exhibit 99.1 to this Form 8-K.</font></p>
<p align="left"><font size="2" face="serif"><b>Item 9.01&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</b></font></p>  <table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="10%"><font size="2" face="serif">&nbsp;</font></td>
<td align="left" width="3%"><font size="2" face="serif">(d)</font></td>
<td align="left"><font size="2" face="serif">Exhibits.</font></td>
</tr>
<tr valign="top">
<td width="10%">&nbsp;</td>
<td width="3%">&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td width="10%" align="left"><font size="2" face="serif">&nbsp;</font></td>
<td width="3%" align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">99.1 &#150; Press release dated January 2, 2007.</font></td>
</tr>
</table>
<p align="center"><font size="2" face="serif"><b>EXHIBIT INDEX</b></font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top">
<td width="10%" align="left"><u><font size="2" face="serif">Exhibit No.</font></u></td>
<td align="left"><font size="2">&nbsp;</font></td>
<td align="left"><u><font size="2" face="serif">Description</font></u></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td width="10%" align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#ffffff">
<td width="10%" align="left"><font size="2" face="serif">99.1</font></td>
<td align="left" width="2%">&nbsp;</td>
<td width="82%" align="left"><font size="2" face="serif">Press release dated January 2, 2007</font></td>
<td width="2%" align="left">&nbsp;</td> </tr>
</table>
<p align="center"><font size="2" face="serif"><b>SIGNATURES</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p align="left"><font size="2" face="serif">Dated:  January 8, 2007</font></p>  <table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="50%" align="left"><font size="2" face="serif">&nbsp;</font></td>
<td colspan="2" align="left"><font size="2" face="serif">IMPAX LABORATORIES,
    INC.</font></td>
</tr>
<tr valign="top">
<td width="50%">&nbsp;</td>
<td width="5%">&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td width="50%" align="left"><font size="2" face="serif">&nbsp;</font></td>
<td width="5%" align="left"><font size="2" face="serif">By: </font></td>
<td align="left"><u><font size="2" face="serif">/s/ Arthur A. Koch, Jr.</font></u></td>
</tr>
<tr valign="top">
<td width="50%" align="left"><font size="2" face="serif">&nbsp;</font></td>
<td width="5%" align="left"><font size="2" face="serif">Name:</font></td>
<td align="left"><font size="2" face="serif">Arthur A. Koch, Jr.</font></td>
</tr>
<tr valign="top">
<td width="50%" align="left"><font size="2" face="serif">&nbsp;</font></td>
<td width="5%" align="left"><font size="2" face="serif">Title:</font></td>
<td align="left"><font size="2" face="serif">Chief Financial Officer</font></td>
</tr>
<tr valign="top">
<td width="50%">&nbsp;</td>
<td width="5%">&nbsp;</td>
<td>&nbsp;</td> </tr>
</table>
<p align="center"><font size="2" face="serif">2</font></p>
<hr noshade align="center" width="100%" size="2">
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "b416715_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 10064}]
{"company-data": {"conformed-name": "IMPAX LABORATORIES INC", "cik": "0001003642", "assigned-sic": "2834", "irs-number": "650403311", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-27354", "film-number": "07517075"}, "business-address": {"street1": "30831 HAYWARD AVE", "city": "HAYWARD", "state": "CA", "zip": "94544", "phone": "2152892220"}, "mail-address": {"street1": "CASTOR & KENSINGTON AVENUES", "city": "PHILADELPHIA", "state": "PA", "zip": "19124-5694"}, "former-company": {"former-conformed-name": "GLOBAL PHARMACEUTICAL CORP \\DE\\", "date-changed": "19951117"}}
Prepared and filed by St Ives Financial
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):  December 29, 2006
Impax Laboratories, Inc.
(Exact name of registrant as specified in its charter)
Delaware
0-27354
65-0403311
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
30831 Huntwood Ave., Hayward, CA 94544
(Address of principal executive offices) (Zip Code)
510-476-2000
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01   Other Events.
On December 29, 2006, the Securities and Exchange Commission issued an order instituting an administrative proceeding to determine whether, in light of the registrant's failure to file periodic reports since September 2004, the registration of its securities under Section 12 of the Securities Exchange Act of 1934 should be suspended or revoked.  An Administrative Law Judge will consider the evidence in this matter and is ordered to issue an initial decision within 120 days.  Also on December 29, 2006, the SEC suspended trading in Impax shares during the 10-business-day period from December 29, 2006 through January 16, 2007 because of the registrant's failure to file periodic reports.
A copy of Impax's press release concerning the foregoing is attached as Exhibit 99.1 to this Form 8-K.
Item 9.01   Financial Statements and Exhibits.
(d)
Exhibits.
99.1 – Press release dated January 2, 2007.
EXHIBIT INDEX
Exhibit No.
Description
99.1
Press release dated January 2, 2007
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated:  January 8, 2007
IMPAX LABORATORIES,
    INC.
By:
/s/ Arthur A. Koch, Jr.
Name:
Arthur A. Koch, Jr.
Title:
Chief Financial Officer
2